Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
    • Day of Event Info
    • Course And Directions
    • Volunteers
    • Team Info
    • Tribute Path
    • Contact Us
    • 2019 Miles For Myeloma Photos
  • Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events

  • Myeloma Crowd: Adding Isatuximab (Sarclisa) to the Myeloma Treatment Arsenal
  • Myeloma Crowd: Mid-Year ASCO 2020 Myeloma Update
  • Patient Power: Answers Now: The Latest in Blood and Antibody Tests for COVID-19
  • MMRF: Managing Myeloma During the COVID-19 Pandemic
  • Patient Power: Making Sense of New Myeloma Treatments During Coronavirus
  • CancerCare: Update on CAR-T Cell Therapy
  • CancerCare: Managing the Side Effects of Immunotherapy
  • MMRF: Expert Session
  • CancerCare: Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation - New Treatment Approaches
  • CancerCare: Understanding the Role of Immunotherapy in Treating Cancer

Myeloma Crowd: Adding Isatuximab (Sarclisa) to the Myeloma Treatment Arsenal

Myeloma Crowd logoWhat: Webcast audio (!:09:32)
When: Friday June 5, 2020 7:00 PM ET
Where: Web
Access webcast audio

Tags
event
events. webcast
archived
myeloma crowd
isatuximab
sarclisa
Dr. Thomas Martin